Dr. Asnani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-8800Fax+1 617-632-7620
Education & Training
- Massachusetts General HospitalPost-Doctoral Fellowship, 2013 - 2017
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 2011 - 2014
- Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
- Duke University School of MedicineClass of 2008
Certifications & Licensure
- MA State Medical License 2011 - 2026
Publications & Presentations
PubMed
- Cardiotoxicity of Anthracyclines.Elizabeth Balough, Abul Ariza, Aarti Asnani, Christopher W Hoeger
Cardiology Clinics. 2025-02-01 - Cancer therapy-associated cardiotoxicity: A look at frailty.Emma Hanlon, Andrea Nathalie Rosas Diaz, Mina S Sedrak, Jordan B Strom, Aarti Asnani
Journal of Geriatric Oncology. 2024-11-01 - Pre-existing cardiovascular disease is associated with an increased risk of cardiovascular events during Bruton tyrosine kinase inhibitor therapy.Maria J Fernandez Turizo, Eunice Kim, Cancan Zhang, Tuyen Yankama, Gottfried Von Keudell
The Oncologist. 2024-09-08
Authored Content
- Ibrutinib-Associated CardiotoxicityJanuary 2020
- Ibrutinib-Associated CardiotoxicityJanuary 2020
Press Mentions
- Researchers ID Protein That May Protect the Heart During Certain Cancer Treatment RegimensDecember 27th, 2022
- Researchers ID Protein That May Protect the Heart During Certain Cancer Treatment RegimensDecember 27th, 2022
- Heart Health Month Special Edition of BIDMC’s Research & Health News DigestFebruary 4th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: